Correlation Between Avient Corp and CERo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Avient Corp and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avient Corp and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avient Corp and CERo Therapeutics Holdings, you can compare the effects of market volatilities on Avient Corp and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avient Corp with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avient Corp and CERo Therapeutics.

Diversification Opportunities for Avient Corp and CERo Therapeutics

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Avient and CERo is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Avient Corp and CERo Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and Avient Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avient Corp are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of Avient Corp i.e., Avient Corp and CERo Therapeutics go up and down completely randomly.

Pair Corralation between Avient Corp and CERo Therapeutics

Given the investment horizon of 90 days Avient Corp is expected to under-perform the CERo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Avient Corp is 15.53 times less risky than CERo Therapeutics. The stock trades about -0.69 of its potential returns per unit of risk. The CERo Therapeutics Holdings is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  1.98  in CERo Therapeutics Holdings on September 26, 2024 and sell it today you would lose (1.19) from holding CERo Therapeutics Holdings or give up 60.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Avient Corp  vs.  CERo Therapeutics Holdings

 Performance 
       Timeline  
Avient Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avient Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
CERo Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, CERo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Avient Corp and CERo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Avient Corp and CERo Therapeutics

The main advantage of trading using opposite Avient Corp and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avient Corp position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.
The idea behind Avient Corp and CERo Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk